San Mateo . San Diego
News Archives
Home > News > News
News Archive 2006

December 21, 2006
Gemin X Biotechnologies to Present at the 25th Annual JPMorgan Healthcare Conference

December 13, 2006
Athenagen Initiates Phase II Clinical Trial in Alzheimer’s Disease

December 11, 2006
Gemin X Phase 1 Data Show Clinical Activity of GX15-070 in Myelodysplastic Syndromes - Data Presented at American Society of Hematology (ASH) 48th Annual Meeting and Exposition -

November 29, 2006
Endocyte awarded for vitamin-targeted imaging agent

November 27, 2006
Naviscan PET Systems, Inc. Announces the Launch of PEM Flex™ Solo II. A New High Resolution PET Scanner with PEMView™ Software

November 17, 2006
Heart research shifts to early detection

November 9, 2006
Review of Clinical Data from Gemin X Biotechnologies' GX15-070 Program Presented at the 24th Annual Chemotherapy Foundation Symposium

October 24, 2006
Asteres Inc. Awarded Landmark Patent for the Delivery of Finished Prescriptions to Consumers

October 19, 2006
Novocell Announces Creation of Insulin-Producing Pancreatic Endocrine Cells from Human Embryonic Stem Cells -- Major Advance in DevelopingScalable Process to Provide a Renewable Cell Source for Islet-Cell Transplantation in Type 1 Diabetes and All Insulin-Requiring Diabetics

October 19, 2006
Nature Biotechnology Announces Publication of Paper Describing Creation of Insulin-Producing Cells from Human Embryonic Stem Cells by Novocell's K.A. D'Amour, et al.

October 19, 2006
Infrared Spectroscopic System for Examining Coronary Arteries

October 17, 2006
InfraReDx to Play Active Role in 18th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium in Washington

October 11, 2006
Purdue Honors Entrepreneurs for Life-Altering Interventions

September 27, 2006
Athenagen Raises $50 Million in Series B Financing

September 14, 2006
Gemin X Biotechnologies Initiates Phase 2 Clinical Trial Program for GX15-070 In Myelofibrosis and Hodgkin's Lymphoma

September 01, 2006
Next-Gen Innovators

August 29, 2006
Taligen’s TA106 Could Be Lucky Charm Vs. Asthma

August 28, 2006
Specialty PET System — Positron Emission Mammography Improves Resolution
By Dan Harvey, Radiology Today, Vol. 7 No. 17 P. 18

August 28, 2006
Cardionet Recognized as one of "50 Companies to Watch" by Medical Device & Dianostic Industry

August 26, 2006
Rite Aid Launches ScriptCenter ® for Express Prescription Refill Pickup

August 21, 2006
Athenagen Initiates Clinical Development of its Anti-angiogenic Eye Drop Therapy for AMD

July 25, 2006
Altor BioScience Introduces STAR(TM) Multimer Reagents to Measure Disease-Specific Antigen Presentation

July 21, 2006
Giant Food Introduces ScriptCenter ® Prescription Pickup Kiosk at Indianapolis Store

July 10, 2006
Athenagen and Zapaq to Merge: Merge Companies Combine Expertise to Create Leading Neuroscience Company

June 29, 2006
Cylene Presents A Poster at the Annual ASCO Meeting in Atlanta

June 28, 2006
Chimerix Announces Initiation of Phase I Clinical Trial of CMX001, an Oral Treatment for Small Pox Infection

June 15, 2006
Alteer Takes the Risk Out of EMR: A Practice Management Prescription Doctors Can't Refuse

June 15, 2006
Athenagen Announces Publication of Results from a Proof-of-Concept Trial of its Novel alpha-7 Nicotinic Receptor Agonist in Schizophrenia

June 05, 2006
Gemin X Pan-Bcl-2 Inhibitor, GX15-070, Shows Biological Activity in Refractory Solid Tumors and Lymphomas

May 31, 2006
Novocell, JDRF Announce Partnership to Clinically Test Encapsulated Human Islets

May 28, 2006
Chimerix Acquires Lead Compound of Antiviral Agents from University of Michigan

May 16, 2006
Endocyte Announced Patent Issued to Enhance Cancer Targeting in Immunotherapy

May 10, 2006
Anginera Phase I Trial Press Kit

April 20, 2006
Endocyte begins Phase 1 trial of EC145 for treatment of refractory solid tumors

April 18, 2006
Chimerix & USAMRIID Collaborate to Complete Preclinical Development of Small Pox Therapeutic

April 13, 2006
Athenagen Acquires Osprey Pharmaceutical Company..
Adds Clinical-Stage Alzheimer’s Drug Candidate to its Pipeline –

February 20, 2006
ATMs for Rx Refills

February 07, 2006
Theregen announces equity investment from Guidant Corporation to develop Anginera™ epicardial patch

January 23, 2006
Cell Therapy News - Human Cells Applied as Patch Improve Cardiac Function After Heart Attack, According to a Report in Tissue Engineering

January 17, 2006
Theregen receives $1.5 million from Sanderling Ventures
To Conduct Anginera Phase I Trial

January 9, 2006
Xytis merges and raises $24.5M

January 5, 2006
Endocyte Signs Agreement with Bristol-Myers Squibb to Develop and Commercialize Folate-Targeted Chemotherapeutic Agents